Effect of Antioxidant Vitamins on the Oxidant / Antioxidant Status in Patients with Multiple Sclerosis

Dr. Wahda B. Al-Youzbaki

Authors

Dr. Wahda B. Al-Youzbaki

Keywords:

multiple sclerosis, malondialdehyde, ascorbic acid, tocopherol

Abstract

Abstract not found

Downloads

How to Cite

Effect of Antioxidant Vitamins on the Oxidant / Antioxidant Status in Patients with Multiple Sclerosis. (2014). Global Journal of Medical Research, 14(3), 29-34. https://medicalresearchjournal.org/index.php/GJMR/article/view/

Download Citation

References

P. Kidd (2001) Kidd PM. Multiple Sclerosis, an Autoimmune Inflammatory Disease: Prospects for its Integrative Management. 6, 6.

A. Hadzovic-Dzuvo, O. Lepara, A. Valjevac, N. Avdagic, S. Hasic, E. Kiseljakovic (2011) Serum total antioxidant capacity in patients with multiple sclerosis. Bosnian Bas. 11(1), 33-36.

Tavazzi B, Batocchi B, Amorini M (2011) Serum Metabolic Profile in Multiple Sclerosis Patients. Article ID 167156, 8pages.

Acar G (2003) Nitric oxide as an activity marker in multiple sclerosis, J Neurol 2003. 250(5), 588-592. https://doi.org/10.1007/s00415-003-1041-0

Mrowicka Miller E, et Zołyński K, Oxidative sclerosis (2009) Oxidative stress in multiple sclerosis. 27(162), 499-502.

Selak Lu F, Croul O'Connor J, Butunoi Lorenzana C, et al, Oxidative DNA (2000) Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. 177, 95-103.

McDonough Dutta R, Peterson Yin X, Torres Chang A, et al (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. 59, 478-489.

Don Mahad, Iryna Ziabreva, Hans Lassmann, Douglas Turnbull (2008) Mitochondrial defects in acute multiple sclerosis lesions. 131(7), 1722-1735. https://doi.org/10.1093/brain/awn105

Trapp B, Stys P (2009) Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. 8, 80-291.

Geurts Witte ME, deVires HE, van P, neurodegeneration (2010) Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration. 10, 411-418.

Kallaur Oliveira SR, Morimoto Simao ANC, Lopes J, Panis al (2012) Oxidative stress in multiple sclerosis patients in clinical remission: Association with the expanded disability status scale. 321, 49-53.

Higgins GC, Beart PM, Shin YS, Chen MJ, Cheung NS, Nagley P (2010) Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury. 20, 453-473.

Bernadette Kalman, Thomas Leist (2003) A Mitochondrial Component of Neurodegeneration in Multiple Sclerosis. 3(3), 147-158. https://doi.org/10.1385/nmm:3:3:147

Mao P, Reddy H (2010) Is multiple sclerosis a mitochondrial disease?. 1802, 66-79.

Van J, Witte ME, Schreibelt G, de HE (2011) Radical changes in multiple sclerosis pathogenesis. 1812, 141-150.

Tasset I, Agüera E, Sanchez-Lopez F, Feijoo M, Giraldo AI, Cruz AH (2012) Peripheral oxidative stress in relapsing-remitting multiple sclerosis. 45, 440-444.

Lassmann H, Van HJ (2011) The molecular basis of neurodegeneration in multiple sclerosis. 585, 3715-3720.

Pekmezci D (2011) Vitamin E and Immunity. 86, 179-215.

M. Yilmaz, A. Karakoc, N. Caker, F. Toruner, E. duzgun, I. Yetkin (2004) The effect of vitamin E on oxidative stress and metabolic status in diabetes mellitus. 2, 200-205.

De-Hyung Lee, Ralf Gold, Ralf Linker (2012) Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters. 13(9), 1783-1180. https://doi.org/10.3390/ijms130911783

Scott Spitsin SV, Zborek Mikheeva T, Kean RB, Brimer al, Comparison acid (2002) Comparison of uric acid and ascorbic acid in protection against EAE. 33, 1363-1371.

A. Tappel (1998) Will antioxidant nutrients slow aging processes?. 23, 97-105.

John Buege, Steven Aust (1978) Microsomal lipid peroxidation. 52, 302-310. https://doi.org/10.1016/s0076-6879(78)52032-6

Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). 33(11), 1444-1452.

R. Naidoo, M. Knapp (1992) Studies of Lipid Peroxidation Products in Cerebrospinal Fluid and Serum in Multiple Sclerosis and Other Conditions. 38(12), 2449-2454. https://doi.org/10.1093/clinchem/38.12.2449

V. Calabrese, R. Raffaele, E. Cosentino, V. Rizza (1994) Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis. 14, 119-123.

Besler HT, Comoglu S, Okcu Z (2002) Serum Levels of Antioxidant Vitamins and Lipid Peroxidation in Multiple Sclerosis. 5(3), 215-220. https://doi.org/10.1080/10284150290029205

Elżbieta Miller, Małgorzata Mrowicka, Joanna Saluk-Juszczak, Majsterek Ireneusz (2011) The Level of Isoprostanes as a Non-invasive Marker for in vivo Lipid Peroxidation in Secondary Progressive Multiple Sclerosis. 36(6), 1012-1016. https://doi.org/10.1007/s11064-011-0442-1

Karg E, Klivenyi P, Nemeth I, Bencsik K, Pinter S, Vecsei L (1999) Nonenzymatic antioxidants of blood in multiple sclerosis. 246(7), 533-539. https://doi.org/10.1007/s004150050399

S. Vinychuk, G. Donchenko, R. Мorosova, O. Kopchak, E. Pasechnaya, S. Silonov (2004) Prooxidant-antioxidant disbalance in multiple sclerosis and its role in the development of fatigue in patients. 44, 11-12.

Koch M, Ramsaransing GS, Arutjunyan AV, Stepanov M, Teelken A, Heersema DJ (2006) Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis. 253(4), 483-487. https://doi.org/10.1007/s00415-005-0037-3

Besler HT, Comoğlu S (2003) Lipoprotein Oxidation, Plasma Total Antioxidant Capacity and Homocysteine Level in Patients with Multiple Sclerosis. 6(3), 189-196. https://doi.org/10.1080/1028415031000115945

Ferretti G, Bacchetti T, Principi F (2005) Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity Mult Scler 2005. 11(6), 677-682. https://doi.org/10.1191/1352458505ms1240oa

Carlson NG, Rose JW (2006) Antioxidants in multiple sclerosis: do they have a role in therapy?. 20(6), 433-441.

Schreibelt Van Horssen J, Hazes Drexhage J, Dijkstra CD, vander al (2008) Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. 45(12), 1729-1737.

I-Y Choi, S-P Lee, D. Denney, S. Lynch (2011) Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1 H magnetic resonance chemical shift imaging at 3 T. 17(3), 289-296. https://doi.org/10.1177/1352458510384010

Elzbieta Miller, Malgorzata Mrowicka, Katarzyna Malinowska, Krystian Zolynski, Józef Kedziora (2010) Effects of the whole-body cryotherapy on a total antioxidative status and activities of some antioxidative enzymes in blood of patients with multiple sclerosis-preliminary study. 57(1,2), 168-173. https://doi.org/10.2152/jmi.57.168

Jimenez-Jimenez FJ, Molina de Bustos F, Gasalla de Androse C, Orti-Pareja al (1998) Cerebrospinal fluid levels of alphatocopherol in patients with multiple sclerosis. 249, 65-67.

Gueli Salemi G, Battaglieri Vitale F, Guglielmini E, homocysteine, stress factors (2010) Lipids in Health and Disease 2010; 9:. 9, 19.

I. Juranek, S. Bezek (2005) Controversy of free radical hypothesis: reactive oxygen speciescause or consequence of tissue injury?. 24, 263-278.

G. Geldern, E. Mowry (2012) The influence of nutritional factors on the prognosis of multiple sclerosis. 8, 678-689.

Mazzanti CM, Spanevello R, Ahmed M (2009) Pre‐treatment with ebselen and vitamin E modulate acetylcholinesterase activity: interaction with demyelinating agents. 27(1), 73-80. https://doi.org/10.1016/j.ijdevneu.2008.09.005

Goudarzvand M, Javan M, Mirnajafi-Zadeh J, Mozafari S, Tiraihi E (2010) Vitamins E and D3 Attenuate Demyelination and Potentiate Remyelination Processes of Hippo-campal Formation of Rats Following Local Injection of Ethidium Bromide. 30, 289-299.